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Background: The hybrid approach to palliation of hypoplastic left heart syndrome (HLHS) utilizing pulmonary artery bands, stent placement in the 
patent ductus arteriosus (PDA), and atrial septostomy has been well described. One potential complication is the development of in-stent stenosis, 
which may obstruct retrograde aortic arch flow, reduce systemic circulation and may lead to interstage interventional procedures. The purpose of this 
study was to evaluate the histopathologic basis for tissue formation in the PDA stent.
Methods: PDA stents were removed from 8 patients undergoing comprehensive stage II repair. Stents were fixed in formalin, examined via 
radiography and embedded in methacrylate or plastic. The vessels were sectioned and stained with hematoxylin and eosin, Movat pentachrome, ± 
smooth muscle actin, and PCNA. Retrospective chart review of the patients was performed.
Results: PDA stents had been in place for a mean of 169 days ± 28 days in patients that had a mean age of 176 ± 30 days at the time of stent 
removal. Histologic evaluation demonstrated the presence of a thickened neointima formed in part by smooth muscle cells. Stent implantation 
caused chronic inflammation in areas immediately surrounding the struts characterized by a hypocellular, myxoid luminal zone and a deeper cellular 
zone, which included spindle-shaped cells with morphologic features of smooth muscle. High magnification demonstrated chronic inflammatory cells 
and focal fibrin deposition around the struts of the stent. 
Conclusions: Neointimal thickening occurs in the PDA after stent placement for hybrid palliation of HLHS, and is the result of cellular proliferation 
and extracellular matrix deposition. The neointima is less cellular, has more extracellular matrix on the luminal surface when compared to the medial 
surface and has chronic inflammatory cells and fibrin deposition around the struts of the stent. Further characterization of the extent, frequency and 
timing of neointimal formation following PDA stenting, as well as its molecular composition, is required to identify potential molecular targets for 
therapeutic intervention.
